Rgenix, Inc.
Records under this name other than the patents Rgenix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,669,296 | LXR Agonists and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,717,704 | Inhibitors of Creatine Transport and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,308,597 | Inhibitors of Creatine Transport and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,613,588 | Anti-Mertk Agonistic Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,827,217 | Pharmaceutically Acceptable Salts of B-Guanidinopropionic Acid with Improved Properties and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,512,623 | Pharmaceutically Acceptable Salts of B-Guanidinopropionic Acid with Improved Properties and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,242,407 | High-Affinity Anti-Mertk Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,174,220 | Metal Salts and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,878,956 | Metal Salts and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,011,427 | Methods of Treating Cancer Formerly held In force · High confidence | In force | High confidence |